Williams-Sonoma must pay $3.2 million for falsely claiming products were “Made in the USA”
Eric Lagatta, USA Today
In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat asthma inhaler will provide 120 doses when, according to plaintiffs, the inhaler contains far fewer dosages, sometimes less than half the advertised amount. (Ignacuinos et al v. Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-672, D. Conn.)
Eric Lagatta, USA Today
Following a complaint by ad watchdog truthinadvertising.org (TINA.org), Pottery Barn’s parent company Williams-Sonoma has agreed to pay more than $3 million for violating a 2020 FTC consent order requiring that…
FTC says civil penalty against Williams-Sonoma is “the largest ever in a Made in USA case.”
The NBA superstar isn’t just cashing endorsement checks.
Lawsuit alleges environmental claims don’t stick.